Pasar al contenido principal

DETECCION PRECOZ DE DISFUNCION COGNITIVA EN SUJETOS CON ENFERMEDAD DE ALZHEIMER PRECLINICA: ASOCIACION DE UNA NUEVA BATERIA COGNITIVA, RESONANCIA MAGNETICA Y BIOMARCADORES EN LCR

PI19/00745

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
Centro realización INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Decreased practice effects in cognitively unimpaired amyloid betapositive individuals, a multicenter, longitudinal, cohort study

  • Tort-Merino, Adrià|||0000-0002-5646-0482
  • Pérez-Millan, Agnès|||0000-0002-3006-9792
  • Falgàs, Neus|||0000-0002-3404-2765
  • Borrego-Écija, Sergi|||0000-0003-2557-0010
  • Esteller Gauxax, Diana|||0000-0003-0975-3052
  • Bosch, Beatriz|||0000-0002-6094-0024
  • Castellví, Magdalena|||0000-0001-8769-9288
  • Juncà-Parella, Jordi|||0000-0002-4772-2647
  • del Val-Guardiola, Andrea|||0000-0002-4536-3644
  • Fernández-Villullas, G.
  • Antonell, Anna|||0000-0002-3286-8459
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Zhu, Nuole|||0000-0002-0015-9455
  • García-Martínez, M.
  • Pozueta, A.
  • Estanga, A.
  • Ecay-Torres, M.
  • de Luis, C.L.
  • Tainta, Mikel|||0000-0003-0624-1211
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Martínez-Lage, P.
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Balasa, Mircea|||0000-0002-1795-4228
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
INTRODUCTION: We aimed to determine whether cognitively unimpaired (CU) amyloid- beta-positive (Aβ+) individuals display decreased practice effects on serial neuropsychological testing. METHODS: We included 209 CU participants from three research centers, 157 Aβ- controls and 52 Aβ+ individuals. Participants underwent neuropsychological assessment at baseline and annually during a 2-year follow-up. We used linear mixed-effects models to analyze cognitive change over time between the two groups, including time from baseline, amyloid status, their interaction, age, sex, and years of education as fixed effects and the intercept and time as random effects. RESULTS: The Aβ+ group showed reduced practice effects in verbal learning (β = -1.14, SE = 0.40, p = 0.0046) and memory function (β = -0.56, SE = 0.19, p = 0.0035), as well as in language tasks (β = -0.59, SE = 0.19, p = 0.0027). DISCUSSION: Individuals with normal cognition who are in the Alzheimer's continuum show decreased practice effects over annual neuropsychological testing. Our findings could have implications for the design and interpretation of primary prevention trials. Highlights: This was a multicenter study on practice effects in asymptomatic Aβ+ individuals. We used LME models to analyze cognitive trajectories across multiple domains. Practice-effects reductions might be an indicator of subtle cognitive decline. Implications on clinical and research settings within the AD field are discussed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Associations of lifestyle factors with amyloid pathology in persons without dementia

  • Vos, Stephanie J.B.|||0000-0002-2045-9818
  • Boada, Mercè|||0000-0003-2617-3009
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Fladby, Tormod|||0000-0002-9984-9797
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Frisoni, Giovanni B.|||0000-0002-6419-1753
  • Grimmer, Timo
  • Hort, Jakub|||0000-0002-1080-3726
  • Iwatsubo, Takeshi
  • Klimkowicz-Mrowiec, Aleksandra
  • Landau, Susan M.
  • Lleó, Alberto|||0000-0002-2568-5478
  • Martinez-Lage, Pablo|||0000-0001-5404-9967
  • de Mendonça, Alexandre|||0000-0002-0488-1453
  • Parchi, Piero
  • Pardini, Matteo
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Popp, Julius|||0000-0002-0068-0312
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Santana, Isabel|||0000-0002-8114-9434
  • Scarmeas, Nikolaos|||0000-0001-6453-8908
  • Scheltens, Philip|||0000-0002-1046-6408
  • Skoog, Ingmar
  • Sperling, Reisa A.
  • Stern, Yaakov
  • Villeneuve, Sylvia
  • Waldemar, Gunhild
  • Wiltfang, Jens
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Bateman, Randall J.
  • Blennow, Kaj|||0000-0002-1890-4193
  • Chipi, Elena
  • Fortea, Juan|||0000-0002-1340-638X
  • Freund-Levi, Yvonne|||0000-0001-6863-6679
  • Handels, Ron
  • Hausner, Lucrezia|||0000-0001-9009-2356
  • Kern, Silke
  • Kornhuber, Johannes|||0000-0002-8096-3987
  • Legdeur, Nienke
  • Levin, Johannes|||0000-0001-5092-4306
  • Maier, Wolfgang
  • Marquié, Marta|||0000-0002-0660-0950
  • Mroczko, Barbara
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Peters, Oliver|||0000-0003-0568-2998
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Selnes, Per
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Spiru, Luiza
  • Teunissen, Charlotte E.|||0000-0002-4061-0837
  • Tijms, Betty M.|||0000-0002-2612-1797
  • Vermunt, Lisa
  • Wallin, Åsa K.
  • Yannakoulia, Mary
  • Zettergren, Anna|||0000-0002-7182-8417
  • Ossenkoppele, Rik
  • Visser, Pieter Jelle|||0000-0001-8008-9727
  • Jansen, Willemijn J.
  • Oomens, Julie E.
  • Maserejian, Nancy N.
  • Didic, Mira
  • Fröhlich, Lutz
  • Dip Gill, Kiran
  • Itoh, Yoshiaki
  • Lee, Dong Young
  • Meyer, Philipp T.
  • Reiman, Eric M.
  • Rinne, Juha O.
  • Rodrigue, Karen M.
  • Allegri, Ricardo F.
  • Altomare, Daniele
  • Baiardi, Simone
  • Baldeiras, Inês|||0000-0002-8106-7308
  • den Braber, Anouk
  • van Buchem, Mark A.
  • Byun, Min Soo
  • Cerman, Jiří
  • Chen, Kewei
  • Day, Gregory S.
  • Drzezga, Alexander
  • Ekblad, Laura L.
  • Förster, Stefan
  • Frings, Lars
  • Guedj, Eric
  • Habeck, Christian G.
  • Hellwig, Sabine
  • Jiménez-Bonilla, Julio F.
  • Iriondo Juaristi, Ane
  • Kandimalla, Ramesh
  • Bordewick Kirsebom, Bjørn Eivind S.
  • Minatani, Shinobu
  • Morbelli, Silvia Daniela
  • Ntanasi, Eva
  • Resende de Oliveira, Catarin
  • Prabhakar, Sudesh
  • Ramakers, Inez H.
  • Rodríguez-Rodriguez, Eloy
  • Rüther, Eckart
  • Sakhardande, Jayant
  • Silva, Dina
  • Takeda, Akitoshi
  • Wiels, Wietse
  • Yi, Dahyun
  • Verhey, Frans R.J.
Background: The association between lifestyle factors and Alzheimer's disease (AD) pathophysiology remains incompletely understood. Objective: The aim of this study was to assess the association of alcohol consumption, smoking behavior, sleep quality and physical, cognitive, and social activity with cerebral amyloid pathology. Methods: For this cross-sectional study, we selected participants from the Amyloid Biomarker Study data pooling initiative. We used generalized estimating equations to assess associations of dichotomized lifestyle measures with amyloid pathology. Results: We included 9171 participants with normal cognition (NC) and 2555 participants with mild cognitive impairment (MCI) from the Amyloid Biomarker Study. Of participants with NC, 58% were women, 34% were APOE ε4 carrier, and 27% had amyloid pathology. Of participants with MCI, 48% were women, 47% were APOE ε4 carrier, and 57% had amyloid pathology. In NC, cognitively active participants were less likely to have amyloid pathology (OR = 0.77, 95%CI 0.66-0.89, p < 0.001). In MCI, participants who had ever smoked or had sleep problems were less likely to have amyloid pathology (OR = 0.85, 95%CI 0.73-0.99, p = 0.029; OR = 0.62, 95%CI 0.45-0.86, p = 0.004). Conclusions: In NC, cognitive activity was associated with a lower frequency of amyloid pathology. In MCI, favorable lifestyle behaviors were not associated with a lower frequency of amyloid pathology. The results of the current study contribute to the broader evidence base on lifestyle and AD by further characterizing the role of lifestyle behaviors in AD pathology across different clinical stages.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Accelerated long-term forgetting over three months in asymptomatic APOE ɛ4 carriers

  • Tort-Merino, Adrià|||0000-0002-5646-0482
  • Laine, Matti J.
  • Valech, Natalia
  • Olives, Jaume
  • León, María
  • Ecay-Torres, Mirian|||0000-0001-7170-6180
  • Estanga, Ainara|||0000-0002-6616-314X
  • Martinez-Lage, Pablo|||0000-0001-5404-9967
  • Fortea, Juan|||0000-0002-1340-638X
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Rodriguez-Fornells, Antoni|||0000-0002-3249-6931
Accelerated long-term forgetting (ALF) refers to a rapid loss of information over days or weeks despite normal acquisition/encoding. Notwithstanding its potential relevance as a presymptomatic marker of cognitive dysfunction, no study has addressed the relationship between ALF and Alzheimer's disease (AD) biomarkers. We examined ALF in APOE ɛ4 carriers versus noncarriers, and its relationships with AD cerebrospinal fluid (CSF) biomarkers. We found ALF over three months in APOE ɛ4 carriers (F(1,19) = 5.60; P < 0.05; Cohen's d = 1.08), and this performance was associated with abnormal levels of the CSF Aβ/ptau ratio (r = -.614; P < 0.01). Our findings indicate that ALF is detectable in at-risk individuals, and that there is a relationship between ALF and the pathophysiological processes underlying AD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characteristics of subjective cognitive decline associated with amyloid positivity

  • Janssen, Olin|||0000-0002-8341-0958
  • Jansen, Willemijn J.
  • Vos, Stephanie J.B.|||0000-0002-2045-9818
  • Boada, Mercè|||0000-0003-2617-3009
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Gabryelewicz, Tomasz
  • Fladby, Tormod|||0000-0002-9984-9797
  • Molinuevo, José Luis|||0000-0003-0485-6001
  • Villeneuve, Sylvia
  • Hort, Jakub|||0000-0002-1080-3726
  • Epelbaum, Stéphane
  • Lleó, Alberto|||0000-0002-2568-5478
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Landau, Susan
  • Popp, Julius|||0000-0002-0068-0312
  • Wallin, Anders|||0000-0001-9506-0513
  • Scheltens, Philip|||0000-0002-1046-6408
  • Rikkert, Marcel Olde|||0000-0003-1397-1677
  • Snyder, Peter J.|||0000-0003-0555-4654
  • Rowe, Chris
  • Chételat, G.|||0000-0002-4889-7932
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Marquié, Marta|||0000-0002-0660-0950
  • Chipi, Elena
  • Wolfsgruber, Steffen
  • Heneka, Michael|||0000-0003-4996-1630
  • Boecker, Henning|||0000-0003-2346-0598
  • Peters, Oliver|||0000-0003-0568-2998
  • Jarholm, Jonas
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Tort-Merino, Adrià|||0000-0002-5646-0482
  • Pichet Binette, Alexa|||0000-0001-5218-3337
  • Poirier, Judes
  • Rosa-Neto, Pedro|||0000-0001-9116-1376
  • Cerman, Jiri
  • Dubois, Bruno
  • Teichmann, Marc
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Ebenau, Jarith
  • Pocnet, Cornelia
  • Eckerström, Marie
  • Thompson, Louisa
  • Villemagne, Victor
  • Buckley, Rachel|||0000-0002-5356-5537
  • Burnham, Samantha
  • Delarue, Marion
  • Freund-Levi, Yvonne|||0000-0001-6863-6679
  • Wallin, Åsa K.
  • Ramakers, Inez
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Hampel, Harald
  • Spiru, Luiza
  • Tijms, Betty M.|||0000-0002-2612-1797
  • Ossenkoppele, Rik
  • Verhey, Frans
  • Jessen, Frank
  • Visser, Pieter Jelle|||0000-0001-8008-9727
Introduction: The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited. Methods: In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD-specific characteristics (informant confirmation, domain-specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene (APOE) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity. Results: Between cohorts, amyloid positivity in 70-year-olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant-confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages. Discussion: Next to age, setting, and APOE ε4 carriership, SCD-specific characteristics may facilitate the identification of amyloid-positive individuals.